OPTINAX Trademark

Trademark Overview

On Wednesday, June 10, 2009, a trademark application was filed for OPTINAX with the United States Patent and Trademark Office. The USPTO has given the OPTINAX trademark a serial number of 77756370. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 25, 2013. This trademark is owned by Glaxo Group Limited. The OPTINAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
optinax

General Information

Serial Number77756370
Word MarkOPTINAX
Filing DateWednesday, June 10, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 25, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 3, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 15, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 25, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 25, 2013ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 2, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 1, 2012EXTENSION 5 GRANTED
Thursday, July 19, 2012EXTENSION 5 FILED
Thursday, July 19, 2012TEAS EXTENSION RECEIVED
Friday, January 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 19, 2012EXTENSION 4 GRANTED
Thursday, January 12, 2012EXTENSION 4 FILED
Thursday, January 12, 2012TEAS EXTENSION RECEIVED
Saturday, July 9, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 8, 2011EXTENSION 3 GRANTED
Wednesday, July 6, 2011EXTENSION 3 FILED
Wednesday, July 6, 2011TEAS EXTENSION RECEIVED
Friday, December 24, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 23, 2010EXTENSION 2 GRANTED
Wednesday, December 8, 2010EXTENSION 2 FILED
Wednesday, December 8, 2010TEAS EXTENSION RECEIVED
Friday, August 13, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 12, 2010EXTENSION 1 GRANTED
Thursday, July 8, 2010EXTENSION 1 FILED
Thursday, August 12, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 8, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 26, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 3, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 3, 2009PUBLISHED FOR OPPOSITION
Monday, October 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 25, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 25, 2009ASSIGNED TO LIE
Tuesday, September 15, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 10, 2009ASSIGNED TO EXAMINER
Monday, June 15, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 13, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

optinax pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic